BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 447,494,000 US dollars
- Current assets
- 135,198,000 US dollars
- Non-current assets
- 312,296,000 US dollars
- Liabilities
- 27,491,000 US dollars
- Current liabilities
- 13,947,000 US dollars
- Non-current liabilities
- 13,544,000 US dollars
- Equity
- 420,003,000 US dollars
- Available-for-sale securities, current portion
- 58,419,000 US dollars
- Inventories
- 35,591,000 US dollars
- Cash and cash equivalents
- 23,997,000 US dollars
- Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively
- 10,652,000 US dollars
- Prepaid expenses and other current assets
- 6,539,000 US dollars
- Goodwill
- 208,587,000 US dollars
- Deferred tax assets, net
- 42,233,000 US dollars
- Available-for-sale securities, long-term
- 30,654,000 US dollars
- Property and equipment, net
- 15,235,000 US dollars
- Operating lease right-of-use assets, net
- 8,644,000 US dollars
- Intangible assets, net
- 3,654,000 US dollars
- Other assets
- 3,289,000 US dollars
- Accrued expenses and other current liabilities
- 6,798,000 US dollars
- Lease liabilities, operating, current portion
- 2,593,000 US dollars
- Accounts payable
- 2,482,000 US dollars
- Sales taxes payable
- 2,074,000 US dollars
- Debt, current portion
- 0 US dollars
- Lease liabilities, operating, long-term
- 13,145,000 US dollars
- Other long-term liabilities
- 399,000 US dollars
- Deferred tax liabilities
- 0 US dollars
- Additional paid-in capital
- 713,571,000 US dollars
- Common stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025
- 49,000 US dollars
- Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025
- 0 US dollars
- Accumulated deficit
- negative 293,406,000 US dollars
- Accumulated other comprehensive (loss) income, net of tax
- negative 211,000 US dollars
- Gross equity (calculated)
- 713,620,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
